SCHEMBL1137962

SCHEMBL1137962

CC(=CCBr)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1137959 1.00
SCHEMBL1774518 0.79 AKR1C3 (0.42)
SCHEMBL1774515 0.79 AKR1C3 (0.42)
SCHEMBL1765494 0.79 CD81 (0.44)
SCHEMBL129059 0.79 CD81 (0.44)
SCHEMBL449325 0.78
SCHEMBL449323 0.78
SCHEMBL4558754 0.77
SCHEMBL17819 0.77
SCHEMBL21943 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113511971-B 4-halogenated-2-methyl-2-butenoic acid ethyl ester and preparation method thereof 上虞新和成生物化工有限公司 2024-01-30 CN claimed
US-20260116838-A1 NEOCARZILIN DERIVATIVES AS ANTIMETASTATIC AGENTS PURDUE RESEARCH FOUNDATION (US) 2026-04-30 US disclosed
CN-118754805-A Preparation method of crocetin 八叶草健康产业研究院(厦门)有限公司 2024-10-11 CN disclosed
EP-3383377-B1 COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE PROCTER & GAMBLE (US) 2024-04-17 EP disclosed
CN-113511971-B 4-halogenated-2-methyl-2-butenoic acid ethyl ester and preparation method thereof 上虞新和成生物化工有限公司 2024-01-30 CN disclosed
CN-116082154-A Method for preparing 4-halogeno-2-methyl-2-butenoate by one-pot method 万华化学集团股份有限公司 2023-05-09 CN disclosed
EP-3980126-A1 BENZO[H][1,6] NAPHTHYRIDIN-2(1H)-ONES AS BMX INHIBITORS, FOR USE AGAINST CANCER Instituto de Medicina Molecular João Lobo Antunes (PT) 2022-04-13 EP disclosed
CN-113511971-A 4-halogenated-2-methyl-2-ethyl crotonate and preparation method thereof 上虞新和成生物化工有限公司 2021-10-19 CN disclosed
EP-3778571-A1 (2E,4E)-5-PHENYL-PENTA-2,4-DIEN-1-ONE DERIVATIVE Bioway, Inc. (KR) 2021-02-17 EP disclosed
WO-2020245430-A1 BENZO[H][1,6] NAPHTHYRIDIN-2(1H)-ONES AS BMX INHIBITORS, FOR USE AGAINST CANCER INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (PT) 2020-12-10 WO disclosed
WO-1991000274-A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED TRP-PHE- AND PHENETHYLAMINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1991-01-10 WO disclosed
EP-0405537-A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives WARNER-LAMBERT COMPANY (US) 1991-01-02 EP disclosed
EP-0232912-A1 Hydroxamic acids of 7-oxabicycloheptane substituted ethers E.R. Squibb &amp; Sons, Inc. (US) 1987-08-19 EP disclosed
US-4654366-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, ANTIPSORIATIC E. R. SQUIBB & SONS, INC. (US) 1987-03-31 US disclosed
US-4524151-A 7-Oxabicycloheptane thio ethers useful as cardiovascular agents E. R. SQUIBB & SONS, INC. (US) 1985-06-18 US disclosed
US-4469697-A ANTIDEPRESSANTS BEECHAM GROUP P.L.C. (GB) 1984-09-04 US disclosed
EP-0055546-B1 PENTACYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE BEECHAM GROUP PLC (GB) 1984-08-01 EP disclosed
US-4442098-A CENTRAL NERVOUS SYSTEM DISORDERS BEECHAM GROUP LIMITED (GB) 1984-04-10 US disclosed
EP-0090552-A2 Pentacyclic compounds BEECHAM GROUP PLC (GB) 1983-10-05 EP disclosed
EP-0055546-A1 Pentacyclic compounds, processes for their preparation and their use BEECHAM GROUP PLC (GB) 1982-07-07 EP disclosed